Norway’s first Ebola patient is to receive the world’s last available dose of the experimental drug ZMapp. The Norwegian Medical Agency’s medical director confirmed the treatment – which was also given to Briton William Pooley – was being sent from Canada to Oslo University Hospital.
ZMapp has not been approved in Norway but Steinar Madsen told newspaper Dagens Medicin the agency would allow experimental drugs to be imported where there is an “acute need”.The Norwegian woman contracted Ebola while working for Doctors Without Borders in Sierra Leone.
